Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation
Public ClinicalTrials.gov record NCT02794857. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluates NP001 in patients with amyotrophic lateral sclerosis (ALS) and evidence of systemic inflammation. Half of participants will receive NP001 and the other half will receive placebo.
Study identification
- NCT ID
- NCT02794857
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 138 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 29, 2016 (Actual)
- Primary completion
- Dec 12, 2017 (Actual)
- Completion
- Dec 12, 2017 (Actual)
- Last update posted
- May 7, 2018
2016 – 2017
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph's Hospital and Medical Center - Barrow Neurology Clinics | Phoenix | Arizona | 85013 | — |
| Mayo Clinic Arizona | Scottsdale | Arizona | 85259 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| University of California, Irvine, Department of Neurology | Orange | California | 92862 | — |
| Forbes Norris MDA/ALS Research Center, CPMC | San Francisco | California | 94115 | — |
| Mayo Clinic Florida | Jacksonville | Florida | 32224 | — |
| University of Miami Miller School of Medicine | Miami | Florida | 33136 | — |
| Emory University, Department of Neurology | Atlanta | Georgia | 30322 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| University of Kentucky, Albert B. Chandler Medical Center | Lexington | Kentucky | 40536-0293 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Clinical & Translational Science Institute, University of Minnesota | Minneapolis | Minnesota | 55414 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Carolinas Medical Center, Neurosciences Instutite-Neurology | Charlotte | North Carolina | 28207 | — |
| Duke Neurological Disorders Clinic at Morreene Road | Durham | North Carolina | 27705 | — |
| Cleveland Clinic Foundation-Cleveland Clinic Hospital | Cleveland | Ohio | 44195 | — |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
| Providence Brain & Spine Institute, ALS Center | Portland | Oregon | 97213 | — |
| Houston Methodist Neurological Institute | Houston | Texas | 77030 | — |
| University of Texas Health Sciences Center San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02794857, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2018 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02794857 live on ClinicalTrials.gov.